ATE234321T1 - Zwischenprodukte und verfahren um aus diesen ein makrolid-antibiotium herzustellen - Google Patents

Zwischenprodukte und verfahren um aus diesen ein makrolid-antibiotium herzustellen

Info

Publication number
ATE234321T1
ATE234321T1 AT99958490T AT99958490T ATE234321T1 AT E234321 T1 ATE234321 T1 AT E234321T1 AT 99958490 T AT99958490 T AT 99958490T AT 99958490 T AT99958490 T AT 99958490T AT E234321 T1 ATE234321 T1 AT E234321T1
Authority
AT
Austria
Prior art keywords
antibiotium
macrolide
processes
producing
intermediate products
Prior art date
Application number
AT99958490T
Other languages
English (en)
Inventor
Tae Suk Lee
Chang Hyun Yoo
Kyoung Soo Kim
Hyun Suk An
Jung Young Kim
Wan Joo Kim
Original Assignee
Chemtech Res Inc
Hansol Chemience Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemtech Res Inc, Hansol Chemience Co Ltd filed Critical Chemtech Res Inc
Application granted granted Critical
Publication of ATE234321T1 publication Critical patent/ATE234321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99958490T 1998-11-24 1999-11-24 Zwischenprodukte und verfahren um aus diesen ein makrolid-antibiotium herzustellen ATE234321T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19980050425 1998-11-24
KR1019990050802A KR100317907B1 (ko) 1998-11-24 1999-11-16 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
PCT/KR1999/000708 WO2000031099A1 (en) 1998-11-24 1999-11-24 Novel intermediates, process for preparing macrolide antibiotic agent therefrom

Publications (1)

Publication Number Publication Date
ATE234321T1 true ATE234321T1 (de) 2003-03-15

Family

ID=26634358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958490T ATE234321T1 (de) 1998-11-24 1999-11-24 Zwischenprodukte und verfahren um aus diesen ein makrolid-antibiotium herzustellen

Country Status (21)

Country Link
US (1) US6600025B1 (de)
EP (1) EP1133511B1 (de)
JP (1) JP3848837B2 (de)
KR (1) KR100317907B1 (de)
CN (1) CN1354753A (de)
AT (1) ATE234321T1 (de)
AU (1) AU751874B2 (de)
BR (1) BR9915646A (de)
CA (1) CA2352162A1 (de)
CZ (1) CZ20011803A3 (de)
DE (1) DE69905935T2 (de)
DK (1) DK1133511T3 (de)
ES (1) ES2190275T3 (de)
HU (1) HUP0104600A3 (de)
IL (1) IL143331A0 (de)
MX (1) MXPA01005248A (de)
PL (1) PL348607A1 (de)
PT (1) PT1133511E (de)
RU (1) RU2208615C2 (de)
TR (1) TR200101474T2 (de)
WO (1) WO2000031099A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
ES2221807B1 (es) * 2003-06-24 2005-12-16 Ercros Industrial, S.A. Un procedimiento para la obtencion de claritromicina.
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2007008537A2 (en) * 2005-07-07 2007-01-18 Elan Pharma International, Limited Nanoparticulate clarithromycin formulations
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) * 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5864023A (en) * 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5929219A (en) * 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
KR20010032613A (ko) * 1997-12-01 2001-04-25 스티븐 에프. 웨인스톡 6-o-알킬 에리트로마이신 c의 화학적 합성 방법
ES2177448B1 (es) * 1997-12-22 2004-08-01 Biochemie S.A. "oxima de eritromicina a.".
AU2658899A (en) * 1998-02-04 1999-08-23 Teva Pharmaceutical Industries Ltd. Process for making clarithromycin

Also Published As

Publication number Publication date
DE69905935T2 (de) 2003-09-04
WO2000031099A1 (en) 2000-06-02
CA2352162A1 (en) 2000-06-02
US6600025B1 (en) 2003-07-29
KR20000057013A (ko) 2000-09-15
RU2208615C2 (ru) 2003-07-20
EP1133511B1 (de) 2003-03-12
TR200101474T2 (tr) 2001-12-21
AU751874B2 (en) 2002-08-29
DE69905935D1 (de) 2003-04-17
BR9915646A (pt) 2001-08-07
EP1133511A1 (de) 2001-09-19
JP3848837B2 (ja) 2006-11-22
MXPA01005248A (es) 2003-08-19
JP2002530423A (ja) 2002-09-17
PT1133511E (pt) 2003-06-30
DK1133511T3 (da) 2003-07-14
AU1584700A (en) 2000-06-13
HUP0104600A2 (hu) 2002-03-28
KR100317907B1 (ko) 2001-12-24
HUP0104600A3 (en) 2003-12-29
CZ20011803A3 (cs) 2001-10-17
ES2190275T3 (es) 2003-07-16
CN1354753A (zh) 2002-06-19
PL348607A1 (en) 2002-06-03
IL143331A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DE69905935D1 (de) Zwischenprodukte und verfahren um aus diesen ein makrolid-antibiotium herzustellen
NZ514917A (en) Ketolide antibacterials
GEP20022838B (en) 5-O-Desosaminyl 6-O-Methyl Erythronolide A Derivatives, Method For Preparing Same
ID28170A (id) Proses untuk pembuatan ayakan molekul
CA2279932A1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
NO20054538L (no) Fremgangsmate for fremstilling av antikonvulsantderivater av topiramat
ATE150758T1 (de) Neue a83543 verbindungen und verfahren zu ihrer herstellung
DK0891370T3 (da) 2'-beskyttede 3'-dimethylamin, 9-etheroxim-erythromycin A-derivater
ES2191982T3 (es) Derivados de 6-o-alquilo de eritronolida b.
WO2002070533A3 (en) Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
MX337751B (es) Sacaridos modificados.
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
ATE273987T1 (de) Neue fucosylierte oligosaccharide und verfahren zu deren herstellung
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
NZ335325A (en) Erythromycin derivatives, method for preparing them and their use as medicine
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
Mukherjee et al. Glycosylation and pyranose-furanose isomerization of carbohydrates using HClO4-SiO2: synthesis of oligosaccharides containing galactofuranose
AU8257701A (en) Process for producing erythromycin derivative
WO2002032916A3 (en) Sixteen-membered macrolide compounds
ES2195727A1 (es) Un procedimiento para la obtencion de claritromicina.
ATE354580T1 (de) Oleandomycin-derivate
ATE488524T1 (de) Kristallines anthracyclin antibiotikum und seine herstellung
TW200801279A (en) Antibiotic and deodorant material and preparation method thereof
YU57900A (sh) Sinteza karbamatno ketolidnih antibiotika
TW200504159A (en) Monoazo compound and process for making same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties